These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 21330637)

  • 1. Diet-induced adipose tissue inflammation and liver steatosis are prevented by DPP-4 inhibition in diabetic mice.
    Shirakawa J; Fujii H; Ohnuma K; Sato K; Ito Y; Kaji M; Sakamoto E; Koganei M; Sasaki H; Nagashima Y; Amo K; Aoki K; Morimoto C; Takeda E; Terauchi Y
    Diabetes; 2011 Apr; 60(4):1246-57. PubMed ID: 21330637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effects of dipeptidyl peptidase-4 (DPP-4) inhibitor against increased β cell apoptosis induced by dietary sucrose and linoleic acid in mice with diabetes.
    Shirakawa J; Amo K; Ohminami H; Orime K; Togashi Y; Ito Y; Tajima K; Koganei M; Sasaki H; Takeda E; Terauchi Y
    J Biol Chem; 2011 Jul; 286(29):25467-76. PubMed ID: 21613229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.
    Liu LF; Purushotham A; Wendel AA; Belury MA
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MK-0626, a selective DPP-4 inhibitor, attenuates hepatic steatosis in ob/ob mice.
    Ohyama T; Sato K; Yamazaki Y; Hashizume H; Horiguchi N; Kakizaki S; Mori M; Kusano M; Yamada M
    World J Gastroenterol; 2014 Nov; 20(43):16227-35. PubMed ID: 25473177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dipeptidyl peptidase-4 inhibitor and sodium-glucose cotransporter 2 inhibitor additively ameliorate hepatic steatosis through different mechanisms of action in high-fat diet-fed mice.
    Iwamoto Y; Kimura T; Dan K; Iwamoto H; Sanada J; Fushimi Y; Katakura Y; Shimoda M; Nogami Y; Shirakiya Y; Nakanishi S; Mune T; Kaku K; Kaneto H
    Diabetes Obes Metab; 2024 Jun; 26(6):2339-2348. PubMed ID: 38504118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
    Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
    Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential antidiabetic efficacy of incretin agonists versus DPP-4 inhibition in high fat fed mice.
    Lamont BJ; Drucker DJ
    Diabetes; 2008 Jan; 57(1):190-8. PubMed ID: 17928394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COH-SR4 reduces body weight, improves glycemic control and prevents hepatic steatosis in high fat diet-induced obese mice.
    Figarola JL; Singhal P; Rahbar S; Gugiu BG; Awasthi S; Singhal SS
    PLoS One; 2013; 8(12):e83801. PubMed ID: 24376752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dipeptidyl peptidase IV inhibitor sitagliptin reduces local inflammation in adipose tissue and in pancreatic islets of obese mice.
    Dobrian AD; Ma Q; Lindsay JW; Leone KA; Ma K; Coben J; Galkina EV; Nadler JL
    Am J Physiol Endocrinol Metab; 2011 Feb; 300(2):E410-21. PubMed ID: 21081706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased plasma dipeptidyl peptidase IV (DPP IV) activity and decreased DPP IV activity of visceral but not subcutaneous adipose tissue in impaired glucose tolerance rats induced by high-fat or high-sucrose diet.
    Kirino Y; Kamimoto T; Sato Y; Kawazoe K; Minakuchi K; Nakahori Y
    Biol Pharm Bull; 2009 Mar; 32(3):463-7. PubMed ID: 19252296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DPP-4 Inhibition with Anagliptin Reduces Lipotoxicity-Induced Insulin Resistance and Steatohepatitis in Male Mice.
    Sakai Y; Chen G; Ni Y; Zhuge F; Xu L; Nagata N; Kaneko S; Ota T; Nagashimada M
    Endocrinology; 2020 Oct; 161(10):. PubMed ID: 32790863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oestrogen alters adipocyte biology and protects female mice from adipocyte inflammation and insulin resistance.
    Stubbins RE; Najjar K; Holcomb VB; Hong J; Núñez NP
    Diabetes Obes Metab; 2012 Jan; 14(1):58-66. PubMed ID: 21834845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conjugated linoleic acid does not reduce body fat but decreases hepatic steatosis in adult Wistar rats.
    Purushotham A; Shrode GE; Wendel AA; Liu LF; Belury MA
    J Nutr Biochem; 2007 Oct; 18(10):676-84. PubMed ID: 17368879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DPP-4 Inhibition by Linagliptin Attenuates Obesity-Related Inflammation and Insulin Resistance by Regulating M1/M2 Macrophage Polarization.
    Zhuge F; Ni Y; Nagashimada M; Nagata N; Xu L; Mukaida N; Kaneko S; Ota T
    Diabetes; 2016 Oct; 65(10):2966-79. PubMed ID: 27445264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary palatinose and oleic acid ameliorate disorders of glucose and lipid metabolism in Zucker fatty rats.
    Sato K; Arai H; Mizuno A; Fukaya M; Sato T; Koganei M; Sasaki H; Yamamoto H; Taketani Y; Doi T; Takeda E
    J Nutr; 2007 Aug; 137(8):1908-15. PubMed ID: 17634263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor-alpha activation and dipeptidyl peptidase-4 inhibition target dysbiosis to treat fatty liver in obese mice.
    Silva-Veiga FM; Miranda CS; Vasques-Monteiro IML; Souza-Tavares H; Martins FF; Daleprane JB; Souza-Mello V
    World J Gastroenterol; 2022 May; 28(17):1814-1829. PubMed ID: 35633911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dipeptidyl peptidase- IV inhibitor alogliptin improves stress-induced insulin resistance and prothrombotic state in a murine model.
    Yisireyili M; Takeshita K; Hayashi M; Wu H; Uchida Y; Yamamoto K; Kikuchi R; Hao CN; Nakayama T; Cheng XW; Matsushita T; Nakamura S; Murohara T
    Psychoneuroendocrinology; 2016 Nov; 73():186-195. PubMed ID: 27509090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additional effect of metformin and celecoxib against lipid dysregulation and adipose tissue inflammation in high-fat fed rats with insulin resistance and fatty liver.
    Lu CH; Hung YJ; Hsieh PS
    Eur J Pharmacol; 2016 Oct; 789():60-67. PubMed ID: 27397427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
    Larter CZ; Yeh MM; Van Rooyen DM; Brooling J; Ghatora K; Farrell GC
    J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.